Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
VERAXA Biotech Provides Business Update and Further Details on Partnering Strategy and Development Timelines
GlobeNewswire, Inc.
ZURICH, SWITZERLAND – July 6, 2026 -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today provided a company and pipeline update. “In the first six months of 2026, we have made substantial...
Pharvaris Announces FDA Acceptance of New Drug Application for Deucrictibant IR for On-Demand Treatment of Hereditary Angioedema Attacks
GlobeNewswire, Inc.
If approved, deucrictibant will be the first oral bradykinin B2 receptor antagonist to treat HAE attacks NDA includes positive data from successful clinical program demonstrating rapid relief and sustained response to resolution of HAE attack...
Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences
GlobeNewswire, Inc.
SAN DIEGO, July 06, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have...
REPRONOVO ANNOUNCES FIRST PARTICIPANT DOSED IN EU PHASE 2 TRIAL OF RPN-002 FOR EMBRYO IMPLANTATION
GlobeNewswire, Inc.
Lausanne, Switzerland and Copenhagen, Denmark, July 06, 2026 (GLOBE NEWSWIRE) -- REPRONOVO ANNOUNCES FIRST PARTICIPANT DOSED IN EU PHASE 2 TRIAL OF RPN-002 FOR EMBRYO IMPLANTATION RPN-002 is an orally administered oxytocin receptor antagonist...
VERAXA Biotech Initiates Cell Line Development with ATUM to Advance its Lead BiTAC®-TCE Program
GlobeNewswire, Inc.
ZURICH, SWITZERLAND – July 02, 2026 -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced the initiation of cell line development for its lead BiTAC® T-cell engager (BiTAC-TCE)...
GENFIT Announces U.S. Medicare Coverage and Future Reimbursement for NASHnext®, a Non-Invasive Diagnostic Technology to Identify Patients with At-Risk MASH
GlobeNewswire, Inc.
Coverage and future reimbursement (effective August 10, 2026) secured for NASHnext®, Labcorp’s non-invasive blood-based diagnostic test powered by GENFIT’s proprietary NIS4® technology Focuses on patients at highest risk, including those with...
Anaveon Appoints Laetitia Pouzol as Chief Scientific Officer
GlobeNewswire, Inc.
BASEL, Switzerland, July 02, 2026 (GLOBE NEWSWIRE) -- Anaveon, a late-stage biotechnology company pioneering precision biologics to reprogram the immune system for the treatment of autoimmune and inflammatory diseases, today announced the...
Furuno to deliver keynote at 'Auden TechDay 2026' in Taiwan
EIN Presswire
NISHINOMIYA, HYOGO, JAPAN, July 6, 2026 /EINPresswire.com/ -- We are pleased to announce that Takahiko Ikeda, General Manager of the Development Department, System Products Division, will deliver a keynote address at the technology conference...
Secro Appoints Guy de Pourtalès As Chief Technology Officer
EIN Presswire
Strengthening SECRO’s bank-grade digital infrastructure, scalability, and AI roadmap for global trade finance documentation GENEVA, SWITZERLAND, July 1, 2026 /EINPresswire.com/ -- SECRO, the trade finance tokenization and document workflow...
Parametric Insurance Market to Reach $34.4 Billion Globally by 2033, Growing at 6.6% CAGR | Allied Market Research
EIN Presswire
Rising Climate Risks, Rapid Claims Processing, AI-Driven Risk Modeling, and Expanding Alternative Risk Transfer Solutions Accelerate Global Market Growth WILMINGTON, DE, UNITED STATES, July 1, 2026 /EINPresswire.com/ -- According to a new report...
Natural Embrace™ Introduces Made in USA High-Tech Skincare for Sensitive Skin
EIN Presswire
LOS ANGELES, CA, UNITED STATES, June 30, 2026 /EINPresswire.com/ -- Natural Embrace™, a USA-based skincare company focused on advanced skin science and natural ingredients, is pleased to announce the introduction of its Made in USA skincare and...
Molecular Partners Updates on Clinical Progress Across Expanding Pipeline of DARPin Radiotherapeutics
GlobeNewswire, Inc.
Phase 1/2a trial of MP0712, 212Pb-based DLL3-targeted Radio-DARPin co-developed with Orano Med: Dosing ongoing in first patients; initial data anticipated within the coming months, comprehensive efficacy data expected in 2027 Additional...
AB Science reports completion of the step 3 of phase 1, evaluating the combination of AB8939 with venetoclax for the treatment of refractory or relapsed AML
GlobeNewswire, Inc.
PRESS RELEASE AB SCIENCE REPORTS COMPLETION OF THE STEP 3 OF PHASE 1, EVALUATING THE COMBINATION OF AB8939 WITH VENETOCLAX FOR THE TREATMENT OF REFRACTORY OR RELAPSED ACUTE MYELOID LEUKEMIA THE COMBINATION OF AB8939 WITH VENETOCLAX GENERATED A 67%...
Usage-Based Insurance Market Growth Accelerates at 13.5% CAGR Through 2035
EIN Presswire
Usage Based Insurance (Ubi) Market Size, Share and Research Report By Vehicle Type (Passenger Cars, Commercial Vehicles (LCV and HCV), 2-Wheelers TOKYO, TOKYO, JAPAN, July 6, 2026 /EINPresswire.com/ -- The Global Usage Based Insurance market...
Beauty&Longevity CHOICE Awards 2027 Open for Entries, Putting Science-Led Beauty & Longevity Innovation in the Spotlight
EIN Presswire
19 categories across four pillars—from skin longevity and metabolic health to diagnostics, devices and biotech.
Switzerland ERP Industry Expands at 11.0% CAGR, Eyeing $1,272.14 Million by 2030 | AMR
EIN Presswire
WILMINGTON, NEW CASTLE, DE, UNITED STATES, June 24, 2026 /EINPresswire.com/ -- According to a recent report published by Allied Market Research, titled, "Switzerland ERP Market by Component, deployment model, business function, end user and...
AMERICAN SWISS FOUNDATION HOSTS 2026 LEADERSHIP SUMMIT IN RÜSCHLIKON, SWITZERLAND
EIN Presswire
"U.S.–Swiss Leadership in Technological Advancements” RÜSCHLIKON, ZÜRICH, SWITZERLAND, June 26, 2026 /EINPresswire.com/ -- On June 16–17, 2026, the American Swiss Foundation convened its annual Leadership Summit at the Swiss Re Centre for Global...
Open worked Dial Watch Market Forecast To Hit $4.01Billion By 2030 Amid Strong Industry Growth
EIN Presswire
The Business Research Company's Open worked Dial Watch Market Forecast To Hit $4.01Billion By 2030 Amid Strong Industry Growth LONDON, GREATER LONDON, UNITED KINGDOM, July 5, 2026 /EINPresswire.com/ -- "The fascination with intricate watch...
Microshare®, Taqt and Zurich Airport announce digital transformation partnership for global airport terminal operations
EIN Presswire
Microshare has launched a partnership with Zurich Airport and device maker Taqt to expand globally its model of integrated, data-driven terminal operations.
Provectus Biopharmaceuticals Launches Veripure™, an Open Science Program for Medical Research Access to PV-10 (rose bengal sodium)
GlobeNewswire, Inc.
Under Veripure, Provectus is supplying qualified medical researchers with the same pharmaceutical grade rose bengal sodium API used in clinical trials.
Sign up for:
Switzerland Tech Review
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.